NeutropeniaFebrile NeutropeniaChemotherapy-Induced Febrile NeutropeniaAntineoplastic Combined Chemotherapy ProtocolsFeverTaxoidsChemotherapy, AdjuvantDrug Administration ScheduleTreatment OutcomeGranulocyte Colony-Stimulating FactorAntineoplastic AgentsCisplatinPaclitaxelNeoplasmsDoxorubicinCyclophosphamideInfusions, IntravenousDeoxycytidineVinblastineDisease-Free SurvivalSurvival AnalysisCombined Modality TherapyAntineoplastic Agents, PhytogenicLung NeoplasmsCamptothecinCarboplatinBreast NeoplasmsAgranulocytosisMaximum Tolerated DoseSurvival RateEtoposideNeoplasm StagingFever of Unknown OriginOrganoplatinum CompoundsIfosfamideMycosesThrombocytopeniaHematologic DiseasesNeoadjuvant TherapyDose-Response Relationship, DrugHematologic NeoplasmsNeoplasm MetastasisCarcinoma, Non-Small-Cell LungLeukopeniaFluorouracilNauseaAnthracyclinesEpirubicinProspective StudiesAntimetabolites, AntineoplasticBacterial InfectionsPrognosisSalvage TherapyNeoplasm Recurrence, LocalLymphoma, Non-HodgkinAnti-Bacterial AgentsMethotrexateOpportunistic InfectionsDrug Resistance, NeoplasmMucositisAntibiotic ProphylaxisImmunocompromised HostVomitingTime FactorsAdenocarcinomaOxonic AcidTegafurDisease ProgressionPenicillanic AcidMitoxantroneLeucovorinAdministration, OralFollow-Up StudiesLeukocyte CountOvarian NeoplasmsAntineoplastic Agents, AlkylatingFeasibility StudiesDrug-Related Side Effects and Adverse ReactionsBleomycinBacteremiaAntibiotics, AntineoplasticPlatinum CompoundsKaplan-Meier EstimateRecombinant ProteinsTopotecanBridged CompoundsGuanineAlopeciaAntifungal AgentsAntibodies, Monoclonal, HumanizedRetrospective StudiesVincristineStomach NeoplasmsColorectal NeoplasmsRecurrencePiperacillinInfectionAntibodies, Monoclonal, Murine-DerivedAmikacinStomatitis